###begin article-title 0
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
-Exfoliation syndrome and exfoliation glaucoma-associated LOXL1 variations are not involved in pigment dispersion syndrome and pigmentary glaucoma
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 342 347 342 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
Single nucleotide polymorphisms (SNPs) in the LOXL1 gene have been implicated in exfoliation syndrome (XFS) and exfoliation glaucoma (XFG). We have shown that these SNPs are not associated with the primary glaucomas such as primary open-angle (POAG) glaucoma and primary angle-closure glaucoma (PACG). To further establish the specificity of LOXL1 SNPs for XFS and XFG, we determined whether these SNPs were involved in pigment dispersion syndrome (PDS) and pigmentary glaucoma (PG).
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 603 608 603 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 161 169 <span type="species:ncbi:9606">patients</span>
Three SNPs of LOXL1 (, , and ) were screened in a cohort of 78 unrelated and clinically well characterized glaucoma cases comprising of PG (n=44) and PDS (n=34) patients as well as 108 ethnically matched normal controls of Caucasian origin. The criteria for diagnosis of PDS/PG were Krukenberg spindle, hyperpigmentation of the trabecular meshwork, and wide open angle. Transillumination defects were detected by infrared pupillography, and the presence of a Zentmayer ring was considered as a confirmatory sign. All three SNPs were genotyped in cases and controls by resequencing the genomic region of LOXL1 harboring these variants and were further confirmed by polymerase chain reaction (PCR)-based restriction digestions. Haplotypes were generated from the genotype data, and the linkage disequilibrium (LD) and haplotype analysis were done with  software that uses the expectation maximization (EM) algorithm.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
The LOXL1 SNPs showed no significant association with PDS or PG. There was no significant difference in the frequencies of the risk alleles of  ('G' allele; p=0.309),  ('G' allele' p=0.461), and  ('T' allele; p=0.432) between PG/PDS cases and controls. Similarly, there was no involvement of the XFS/XFG-associated haplotypes, 'G-G' (p=0.643; [OR=1.08, 95%CI, 0.59-1.97]) and 'T-G' (p=0.266; [OR=1.35, 95%CI, 0.70-2.60]), with the PDS/PG phenotypes. The risk haplotype 'G-G' was observed in ~55% of the normal controls.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
There was no involvement of the LOXL1 SNPs in patients with PDS and PG. The results further indicate that the associations of these SNPs are specific to XFS/XFG.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 388 394 <span type="species:ncbi:9606">people</span>
Glaucoma is a chronic, progressive neurodegenerative disorder characterized by a specific pattern of optic nerve head and visual field damage, which represents the final common pathway of a heterogeneous group of entities that affect the eye [1,2]. It is the second leading cause of irreversible blindness worldwide, and it has been estimated that it will affect approximately 80 million people by the year 2020 [3].
###end p 11
###begin p 12
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 546 547 546 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
Exfoliation syndrome (XFS) is an age-related, generalized disorder of the extracellular matrix characterized by the production and progressive accumulation of a fibrillar extracellular material in many ocular tissues and is the most common identifiable cause of open-angle glaucoma worldwide [4]. It plays an etiologic role in open-angle glaucoma, angle-closure glaucoma, cataract, and retinal vein occlusion and has been associated with an increasing number of systemic disorders including vascular disease, hearing loss, and Alzheimer disease [5-8]. Exfoliation syndrome appears to be a disease of elastic tissue microfibrils.
###end p 12
###begin p 13
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 199 204 199 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
Recently, single nucleotide polymorphisms (SNPs) in the LOXL1 gene () at 15q24.1 have been implicated in exfoliation syndrome and exfoliation glaucoma (XFG) [9]. Two non-synonymous SNPs in exon 1 of LOXL1 ( [R141L] and  [G135D]) were demonstrated to exhibit a strong association with XFS and XFG in an Icelandic and Swedish population [9] that was later replicated across multiple populations worldwide [10-19]. It was also shown that LOXL1 SNPs are not associated with primary glaucomas [20,21].
###end p 13
###begin p 14
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 524 532 <span type="species:ncbi:9606">patients</span>
Pigment dispersion syndrome (PDS; ) and pigmentary glaucoma (PG) are characterized by a disruption of the iris pigment epithelium (IPE) and deposition of the dispersed pigment granules throughout the anterior segment [22]. The classic diagnostic triad consists of corneal pigmentation (Krukenberg spindle); slit-like, radial, mid-peripheral iris transillumination defects; and dense trabecular pigmentation [23]. The iris insertion is typically posterior, and the peripheral iris tends to bow posteriorly [24]. About 80% of patients with PDS are myopes and 20% are emmetropes. The basic abnormality in this hereditary disorder remains unknown.
###end p 14
###begin p 15
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 122 130 <span type="species:ncbi:9606">patients</span>
###xml 391 399 <span type="species:ncbi:9606">patients</span>
The frequency with which PDS converts to PG has probably been greatly overestimated. The three studies that have examined patients longitudinally suggest that up to 50% will eventually develop glaucoma [25-27]. However, the true rate of PDS in the general population may be an order of magnitude greater than has previously been suspected [28]. In a retrospective community-based study, 113 patients of whom nine developed PG or elevated intraocular pressure (IOP) that required therapy were newly diagnosed with PDS over 24 years [29]. The probability of converting to PG was 10% at five years and 15% at 15 years.
###end p 15
###begin p 16
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
PDS/PG is an autosomal dominant disorder and was mapped to the 7q35-q36 locus by linkage analysis [30], although the candidate gene is yet to be identified. While POAG shares several clinical features with PDS, there was no evidence of linkage to the POAG-associated 1q21-q31 locus in PDS, indicating that there would be other candidate loci that are yet uncharacterized [31,32].
###end p 16
###begin p 17
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 232 237 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 279 287 <span type="species:ncbi:9606">patients</span>
XFS and PDS are two common disorders that can produce secondary glaucoma through trabecular blockage [22,33]. To further establish the specificity of this association, we studied the involvement of the three XFS- and XFG-associated LOXL1 SNPs in a cohort of Caucasian PDS and PG patients from New York.
###end p 17
###begin title 18
Methods
###end title 18
###begin title 19
Clinical details of the subjects
###end title 19
###begin p 20
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 238 246 <span type="species:ncbi:9606">patients</span>
The study protocol adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Review Boards of the New York Eye and Ear Infirmary (NYEE) and the L.V. Prasad Eye Institute. The cohort comprised 78 unrelated patients with PG (n=44) and PDS (n=34) seen at the NYEE between 1998 and 2003 along with 108 normal controls. The diagnoses of PDS/PG were independently confirmed by two surgeons based on the inclusion and exclusion criteria mentioned earlier [33]. The criteria for diagnosis of PDS required the presence of Krukenberg spindles, a deep anterior chamber, wide open angles on gonioscopy, and hyperpigmented trabecular meshwork. Transillumination defects were detected by infrared pupillography. A Zentmayer ring was considered to be confirmatory. A pigment reversal sign was only considered as a soft sign and not categorized as PDS. A diagnosis of PG required PDS plus typical glaucomatous optic disc and visual field damage.
###end p 20
###begin p 21
###xml 799 807 <span type="species:ncbi:9606">patients</span>
Normal adult individuals without any signs or symptoms of glaucoma and other systemic diseases served as controls. Their visual acuity ranged from 20/20 to 20/40, and their IOP was less than 21 mmHg. The stereodisc exam did not reveal any changes in the optic disc suggestive of glaucoma. All the subjects underwent visual field testing with the Humphreys visual field analyzer (Carl Zeiss Meditec, Dublin, CA). This was essentially a diagnosis of exclusion: normal pattern of neuroretinal rim, absence of notching or thinning of the rim, and disc hemorrhage or nerve fiber layer defects. The cup/disc ratio related to the disc size, the asymmetry of cup to disc ratio less than or equal to 0.2:1 (corrected for size), and the absence of a beta zone peripapillary atrophy were "soft" signs. All the patients and controls were matched with respect to their ethnicity.
###end p 21
###begin title 22
Molecular analysis
###end title 22
###begin p 23
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 215 220 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 650 652 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 852 860 846 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 865 873 859 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 882 890 876 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 480 488 <span type="species:ncbi:9606">patients</span>
Peripheral blood samples (5-10 ml) were collected from each subject by venipuncture with prior informed consent, and DNA was extracted by standard protocols [34]. The three SNPs in exon 1 ( and ) and intron 1 () of LOXL1 were amplified with pre-designed primers; the amplicons were purified and screened by re-sequencing using BigDye chemistry (version 3.1) on an ABI 3100 DNA Analyzer (Applied Biosystems, Foster City, CA) as described earlier [21]. The genotypes of a subset of patients and controls were further confirmed by restriction digestion of the amplicons at 37 degreesC overnight with appropriate restriction enzymes as detailed earlier [21]. The genotyping was repeated independently by investigators who were masked to the phenotypes. Representative chromatograms displaying all the genotype patterns for these three SNPs are provided in Figure 1 (), Figure 2 (), and Figure 3 ().
###end p 23
###begin p 24
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 136 137 136 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 156 157 156 157 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 182 183 182 183 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 333 334 333 334 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 488 493 488 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 1048 1050 1048 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
Genotype pattern of the LOXL1 SNP  (R141L). The representative electropherograms show the three genotype patterns for the  (G>T) SNP in A (TT; homozygous), B (GT; heterozygous), and C (GG; wild type). The arrow heads indicate the point of substitution. The normal sequence is provided in the upper panel above each electropherogram. D demonstrates the confirmation of these variants by PCR-based restriction digestion in a non-denaturing polyacrylamide gel. The PCR amplicon (464 bp) for LOXL1 (obtained using the primer pairs 5'-GCA GGT GTA CAG CTT GCT CA-3' and 5'-ACA CGA AAC CCT GGT CGT AG-3') after digestion with SmaI cleaved into fragments of 201 bp, 189 bp, and 74 bp in the wild type (lane 4). Presence of the variant abolished the site for this restriction enzyme, generating an intact fragment of 390 bp and 74 bp in the individual homozygous for this variant (lane 2). The individual with the heterozygous variant (lane 3) exhibits all the fragments (390 bp, 210 bp, 189 bp, and 74 bp). Lane 1 contains the 100 bp DNA ladder (Gene RulerTM; MBI Fermentas, Vilnius, Lithuania).
###end p 24
###begin p 25
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 132 133 132 133 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 154 155 154 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 177 178 177 178 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 329 330 329 330 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 484 489 484 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 1023 1025 1023 1025 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
Genotype pattern of the LOXL1 SNP  (G153D). Representative electropherograms show the three genotype patterns for the  (G>A) SNP in A (GA; heterozygous), B (GG; wild type), and C (AA; homozygous). The arrow heads indicate the point of substitution. The normal sequence is provided in the upper panel above each electropherogram. D demonstrates the confirmation of these variants by PCR-based restriction digestion in a non-denaturing polyacrylamide gel. The PCR amplicon (464 bp) for LOXL1 (obtained using the primer pairs 5'-GCA GGT GTA CAG CTT GCT CA-3' and 5'-ACA CGA AAC CCT GGT CGT AG-3') after digestion with HinfI generated an intact fragment of 464 bp in the wild type (lane 3). Presence of the variation generated a restriction site for this enzyme and cleaved into fragments of 311 bp and 153 bp in the individual homozygous for this change (lane 4). The individual heterozygous for this change (lane 2) exhibited all three fragments (464 bp, 311 bp, and 153 bp). Lane 1 contains the 100 bp DNA ladder (Gene RulerTM; MBI Fermentas, Vilnius, Lithuania).
###end p 25
###begin p 26
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 133 134 133 134 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 152 153 152 153 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 176 177 176 177 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 330 331 330 331 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 485 490 485 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 1067 1069 1067 1069 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
Genotype pattern of the intronic LOXL1 SNP . Representative electropherograms show the three genotype patterns for the  (C>T) SNP in A (CC; wild type), B (TT; homozygous), and C (CT; heterozygous). The arrow heads indicate the point of substitution. The normal sequence is provided in the upper panel above each electropherogram. D demonstrates the confirmation of these variants by PCR-based restriction digestion in a non-denaturing polyacrylamide gel. The PCR amplicon (264 bp) for LOXL1 (obtained using the primer pairs 5'-TAG GGC CCC TTG GAG AAT AG-3' and 5'-GTC CCA TTC CCC TCT CAA TC-3') after digestion with SspI generated an intact fragment of 264 bp in the wild type (lane 1). Presence of the variation generated a restriction site for this enzyme and cleaved into fragments of 147 bp and 117 bp in the individual homozygous for this change (lane 2). The individual heterozygous for this change (lane 3) exhibited all three fragments (264 bp, 147 bp, and 117 bp). Lane 4 contains an undigested amplicon, and Lane 5 contains the 100 bp DNA ladder (Gene RulerTM; MBI Fermentas, Vilnius, Lithuania).
###end p 26
###begin title 27
Statistical analysis
###end title 27
###begin p 28
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 374 375 372 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The maximum likelihood estimates of allele frequencies, Hardy-Weinberg equilibrium, and haplotype frequencies were estimated from the genotype data at the three SNP loci using  software that uses the expectation maximization (EM) algorithm [35]. Pairwise linkage disequilibrium (LD) between the individual SNPs was calculated using the LD-plot function of this software. chi2 analysis was done to assess the significance between the allele frequencies. The odds ratios were calculated to assess the risk of the individual alleles of all three SNPs.
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
Distribution of the LOXL1 single nucleotide polymorphisms in pigment dispersion syndrome and pigmentary glaucoma
###end title 30
###begin p 31
###xml 157 164 157 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 403 410 403 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 514 519 514 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
The study cohort conformed to the Hardy-Weinberg equilibrium. The allele frequencies of the three SNPs and their corresponding allele counts are provided in Table 1. There was no significant difference in the frequencies of the XFS/XFG-associated alleles among the PG and PDS patients and controls. The allele frequencies were consistent even after categorizing the data set into PG and PDS phenotypes (Table 1). Similarly, there were no differences in the genotype frequencies of these alleles across these three LOXL1 SNPs in PG and PDS cohorts (data not shown).
###end p 31
###begin title 32
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
Allele frequency distributions across PG/PDS cases and controls for the three LOXL1 SNPs.
###end title 32
###begin title 33
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
Haplotype analysis of the LOXL1 single nucleotide polymorphisms
###end title 33
###begin p 34
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
Haplotypes were generated with the three LOXL1 intragenic SNPs among PG/PDS cases and controls. There was a strong pairwise linkage disequilibrium (LD) between the  and  (D'=0.89, 95%CI, 0.57-0.97) SNPs and between the  and  (D'=1.00, 95%CI, 0.81-1.00) SNPs, similar to earlier studies [11-15,17-20].
###end p 34
###begin p 35
###xml 358 365 358 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
Four different haplotypes could be generated (with frequency greater than 5%) with these three SNPs in PG/PDS patients and controls. There were no significant differences in the haplotype frequencies between the cases and controls. These results were consistent even after reanalysis of the haplotype data with respect to PG and PDS phenotypes and controls (Table 2).
###end p 35
###begin title 36
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Estimated LOXL1 haplotype frequencies of PG/PDS patients and controls.
###end title 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 416 421 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
XFS is the most common identifiable cause of open-angle glaucoma worldwide. It is also associated with extra-ocular abnormalities [36,37]. Recently, intragenic SNPs in LOXL1 were implicated in XFS and XFG in an Icelandic and Swedish population [9]. Several studies conducted on XFS and XFG worldwide were able to independently replicate these findings in geographically and ethnically diverse cohorts [10-19]. Since LOXL1 SNPs were implicated in a secondary glaucoma, we analyzed these variations in PDS/PG to establish the uniqueness of this association. To the best of our knowledge, this is the first report to screen for these SNPs in PG/PDS.
###end p 38
###begin p 39
###xml 277 284 277 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 517 522 517 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 599 606 599 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 381 389 <span type="species:ncbi:9606">patients</span>
###xml 538 546 <span type="species:ncbi:9606">patients</span>
The data from the present study show that the three XFS/XFG-associated SNPs were not involved with PG or PDS. The significant associations of the  (G allele) and the  (G allele) SNPs have been consistent to XFS and XFG across multiple populations worldwide except in Japanese (Table 3). On the contrary, the "T" allele () has exhibited strong association with the Japanese XFS/XFG patients [16,19]. So far, these SNPs have not been involved with primary glaucomas [9,12,20,21]. However, the allele frequencies of the LOXL1 SNPs in PG/PDS patients were similar to that observed in primary glaucomas (Table 3).
###end p 39
###begin title 40
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
Worldwide distribution of allele frequencies and their odds ratios for the three LOXL1 SNPs across all glaucoma phenotypes including the present cohort.
###end title 40
###begin p 41
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 86 93 86 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 551 558 551 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 729 736 729 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 445 453 <span type="species:ncbi:9606">patients</span>
There was no significant association with the LOXL1 haplotypes either with PG or PDS (Table 2). Since most studies had demonstrated a significant risk with haplotypes generated with the  and  SNPs [9-15,17-19], a similar exercise was conducted to draw a comparison of the haplotype structure in the present cohort with other studies. The frequency of the risk haplotype with these two SNPs (G-G) was observed in lower frequency among the PG/PDS patients compared to other studies; this risk haplotype was also present in ~55% of the control subjects (Table 4). Unlike previous studies on XFS and XFG, there was no risk associated with the G-G (OR=1.08, 95%CI, 0.59-1.97) and T-G (OR=1.35, 95%CI, 0.70-2.60) haplotypes in PG/PDS (Table 4).
###end p 41
###begin title 42
The estimated haplotype frequencies and their odds ratios based on two SNPs ( and ) across different secondary glaucoma phenotypes in the present cohort and other populations.
###end title 42
###begin p 43
The asterisk indicates that the odds ratios were calculated with respect to the G-A haplotype. The sharp (hash mark) indicated that the 95%CI were not available in the reported studies.
###end p 43
###begin p 44
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
While PG/PDS occurs relatively early in life, XFS/XFG occurs at a later stage. It has been suggested that certain PDS patients who do not achieve IOP control could later progress to develop XFS/XFG [38]. Based on this, the concept of an "overlap" syndrome has been suggested whereby the sequential appearance of two or more risk factors lead to glaucomatous damage [33].
###end p 44
###begin p 45
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 324 329 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 214 222 <span type="species:ncbi:9606">patients</span>
In summary, we aimed to determine if the LOXL1 SNPs associated with XFS/XFG were involved in another secondary glaucoma. The high population attributable risks for the high-risk haplotype among the diverse XFS/XFG patients strongly suggest that these variants are exclusive to XFS and XFG [9,13]. The non-association of the LOXL1 SNPs in our PG/PDS cohort further supports the fact that these are XFS-specific and may not be involved with other secondary glaucomas. Although PG/PDS share certain discrete clinical features with XFS, their underlying molecular mechanisms remain to be elucidated.
###end p 45
###begin title 46
Acknowledgments
###end title 46
###begin p 47
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 17 25 <span type="species:ncbi:9606">patients</span>
We thank all the patients and the normal volunteers for their participation in this study. The authors would like to take this opportunity to thank Dr. Mansoor Sarfarazi (University of Connecticut Health Center, Farmington, CT) for providing the LOXL1 genotype data for 50 control samples. The study was supported by grants from the Department of Biotechnology (BT/01/COE/06/02/10), Government of India to S.C., and the Daniel Hebert Glaucoma Research Fund of the New York Eye and Ear Infirmary to R.R.
###end p 47
###begin title 48
References
###end title 48
###begin article-title 49
Complex genetics of glaucoma susceptibility.
###end article-title 49
###begin article-title 50
Prevalence of glaucoma. The Beaver Dam Eye Study.
###end article-title 50
###begin article-title 51
###xml 14 20 <span type="species:ncbi:9606">people</span>
The number of people with glaucoma worldwide in 2010 and 2020.
###end article-title 51
###begin article-title 52
Exfoliation syndrome: The most common identifiable cause of open-angle glaucoma.
###end article-title 52
###begin article-title 53
The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type.
###end article-title 53
###begin article-title 54
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Homocysteine levels in plasma and sensorineural hearing loss in patients with pseudoexfoliation syndrome.
###end article-title 54
###begin article-title 55
Exfoliation and carotid stiffness.
###end article-title 55
###begin article-title 56
Sensorineural hearing loss in pseudoexfoliation syndrome.
###end article-title 56
###begin article-title 57
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.
###end article-title 57
###begin article-title 58
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 60 68 <span type="species:ncbi:9606">patients</span>
LOXL1 mutations are associated with exfoliation syndrome in patients from Midwestern United States.
###end article-title 58
###begin article-title 59
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma.
###end article-title 59
###begin article-title 60
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a U.S. clinic-based population with broad ethnic diversity.
###end article-title 60
###begin article-title 61
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
Evaluation of LOXL1 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma.
###end article-title 61
###begin article-title 62
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
Association of LOXL1 common sequence variations in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
###end article-title 62
###begin article-title 63
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India.
###end article-title 63
###begin article-title 64
Lysyl Oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population.
###end article-title 64
###begin article-title 65
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOXL1</italic>
###xml 138 144 <span type="species:ncbi:9606">people</span>
Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people.
###end article-title 65
###begin article-title 66
Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population.
###end article-title 66
###begin article-title 67
Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese.
###end article-title 67
###begin article-title 68
The LOXL1 gene variations are not associated with primary open-angle and primary angle-closure glaucomas.
###end article-title 68
###begin article-title 69
Lack of association between LOXL1 variants and primary open-angle glaucoma in three different populations.
###end article-title 69
###begin article-title 70
Pigmentary dispersion and glaucoma: a new theory.
###end article-title 70
###begin article-title 71
Prevention of blinking alters iris configuration in pigment dispersion syndrome and in normal eyes.
###end article-title 71
###begin article-title 72
Long-term analysis of pigmentary dispersion syndrome and pigmentary glaucoma.
###end article-title 72
###begin article-title 73
Pigmentary dispersion syndrome and pigmentary glaucoma. A prospective study of the natural history.
###end article-title 73
###begin article-title 74
Risk factors for the development and severity of glaucoma in the pigment dispersion syndrome.
###end article-title 74
###begin article-title 75
Prevalence of pigment dispersion syndrome in a population undergoing glaucoma screening.
###end article-title 75
###begin article-title 76
What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome?
###end article-title 76
###begin article-title 77
A gene responsible for the pigment dispersion syndrome maps to 7q35-q36.
###end article-title 77
###begin article-title 78
Exclusion of chromosome 1q21-q31 from linkage to three pedigrees affected by the pigment-dispersion syndrome.
###end article-title 78
###begin article-title 79
Clinical features of five pedigrees genetically linked to the juvenile glaucoma locus on chromosome 1q21-q31.
###end article-title 79
###begin article-title 80
Combined exfoliation and pigment dispersion: Paradigm of an overlap syndrome.
###end article-title 80
###begin article-title 81
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 81
###begin article-title 82
Association between LOXL1 and pseudoexfoliation.
###end article-title 82
###begin article-title 83
The molecular pathophysiology of pseudoexfoliation glaucoma.
###end article-title 83
###begin article-title 84
Ritch R, King DG, Teekhasaenee C. Combined exfoliation and pigment dispersion syndrome.
###end article-title 84

